GPP-backed Softbox buys TP3

Softbox Systems, a portfolio company of Great Point Partners, has acquired UK-based TP3 Global, a maker of thermal protection covers for the pharmaceutical sector. No financial terms were disclosed.


GREENWICH, CT and LONG CRENDON, U.K. – Great Point Partners (“GPP”) today announced that Softbox Systems (“Softbox”) a GPP II portfolio company has acquired TP3 Global (“TP3”) based in Redditch, U.K. TP3 is one of the world’s leading manufacturers of thermal protection covers for the pharmaceutical industry, with operations in North America, Europe, the Middle East, and Africa (“EMEA”) and Asia Pacific.

The combination of Softbox and TP3 Global’s industry-leading passive temperature-control solutions (Silverskin, SilverQuilt, and PalletQuilt) will expand Softbox’s product portfolio, technical capabilities and geographic footprint
Noah Rhodes, Managing Director at GPP, commented “The acquisition of TP3 Global is important as customers continue to see tightening regulations for their controlled room temperature (“CRT”) shipments. TP3’s products address the fluctuations in ambient room temperature shipments and are used to protect pharmaceuticals that need to be kept between 15-25°C, 2-40°C, 2-30°C, or short durations of 2-8°C.”

Wayne Langlois, President of Softbox, commented “Clive Wheeldon and his leadership team, TP3’s global brands in Silverskin, and its global manufacturing infrastructure will remain in place with the combination of Softbox and TP3 Global into one Softbox enterprise. We now provide expanded global leadership for our customers in Europe, the U.S., India and Latin America.”

Clive Wheeldon, President of TP3 Global commented: “The strong cultural fit, complementary products and the potential of combining the outstanding technical capabilities of each company made the decision to join Softbox the next logical step in the development of TP3 Global. The combined global footprint is unrivaled within the Temperature Controlled Packaging Industry, enabling us to provide unsurpassed levels of product availability on a local basis.”

About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with approximately $1.1 billion of equity capital under management and 28 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new private equity investments from GPP II, which has closed on $215 million. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million) and public (BioMedical Value Fund, approximately $675 million) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Reach Great Point at 203-971-3300 or

About Softbox Systems
Softbox Systems based in Long Crendon, U.K. is an award winning temperature control packaging innovator that has been designing and producing high performance passive temperature control packaging solutions for over 20 years. The Company offers consistent quality to our clients from our strategically located global manufacturing sites throughout Europe, North America, Latin America and Asia Pacific.

Softbox has formed long standing partnerships with the world’s leading biotech, pharmaceutical, clinical research and logistics companies, and apply innovative thinking to overcome the challenges that our clients face in managing the Cold Chain when shipping temperature sensitive clinical trial and commercialised products. For more information on Softbox please visit